Sanofi Mexico will invest 129 million euros to position the pharmaceutical industry in the country

Sanofi confirmed that it will make an investment of 129 million euros , a project that will allow Mexico to be self-sufficient in the production of vaccines against seasonal influenza , starting in 2024.

In the framework of the presentation of the investment projects, Fernando Antunes Sampaio, general director of Sanofi Mexico, declared that this injection of capital is added to the agreement between Sanofi Pasteur and the Government of Mexico , they are the basis of the " Azteca Project",  which will guarantee the annual supply of 32 million doses of influenza vaccines for 15 years , an action with which the country will always have available one of the most requested vaccines globally.

In the working meeting with Alfredo Del Mazo Maza, governor of the State of Mexico, the plan to modernize the plant of this company in the municipality of Ocoyoacac was also presented , where it is evaluated to start two upgrade projects, which will allow the production of state- of-the-art probiotics , as well as the modernization and automation of its existing processes.

With this, Sanofi will  promote scientific and technological innovation in Mexico, will also strengthen its social presence in this region, and will consolidate the advantages of the state as a destination for productive investment.

The state president stressed that the strategic decision of the pharmaceutical company to carry out these projects in Mexico will consolidate the regional leadership of the branch and strengthen the value chains of the industrial and manufacturing sector.

Likewise, he recognized the social and economic impact of Sanofi's  presence in Ocoyoacac, where the company built the largest influenza antigen plant in Latin America , which, in addition to generating 800 jobs, produces more than 30 million annual doses against seasonal influenza.

It is worth mentioning that Sanofi Mexico is a world leader in the production of vaccines, its products prevent 20 of the most well-known infectious diseases , among which influenza, dengue, diphtheria, tetanus, and polio stand out, among others, in benefit of millions of people around the world.

This meeting was attended by the secretaries of Health and Economic Development , Francisco Fernández Clamont and Pablo Peralta García, respectively, as well as Paola Martorelli Hernández, director of public affairs of Sanofi México, Karen García Valdivia, manager of public affairs of Sanofi México, among others.